Latest filing published 24 Sept 2021 for Strides Pharma Science Limited, €29k.
Filing timeline
BuySaleSandeep Baid: trading record in brief
All filings by Sandeep Baid on record concern Strides Pharma Science Limited, in the capacity of chief executive. We count 2 filings; the first trade dates from 6 September 2021 and the latest from 22 September 2021.
The open-market record consists of 1 sale worth €29k, with no purchase. Outside the open market, there are 1 share grant.
Most recently, on 24 September 2021, the filings show an open-market sale worth €29k in Strides Pharma Science Limited. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sandeep Baid
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,000 shares@ ₹628.850367.7% of flowEquity SharesSEBI:bb89d6aeb99a1b397593d54f772b4b40a519282f
- 4,000 shares@ ₹301.000.0000% mcap100.0% of flowEquity SharesSEBI:05255a66d070fc71fce0544ea378e9c1ee91e8b4Canonical exit: 5 Dec 2021 (T+90)
2 of 2 declarations